• Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous; Note=2 out of 3 copies (PubMed=16364757).
  

PubMed=11062710
Julia Krystyna Bar, Antonina Urszula Harlozinska-Szmyrka;
Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
Anticancer Res. 20:2975-2980(2000)

CLPUB00470
Julia Krystyna Bar, Antonina Urszula Harlozinska-Szmyrka, Ewa Wyrodek, Sabine Kartarius, Mathias Montenarh, Jan Manuel Rodriguez-Parkitna, Marian Kochman, Andrzej Ozyhar;
A characterization of the temperature-sensitivity of an ovarian carcinoma cell line (OvBH-1), independent of p53 status.
Cell. Mol. Biol. Lett. 7 Suppl. 1:80-80(2002)

PubMed=12359050; DOI=10.1111/j.1349-7006.2002.tb02473.x; PMCID=PMC5927136
Julia Krystyna Bar, Antonina Urszula Harlozinska-Szmyrka, Sabine Kartarius, Mathias Montenarh, Ewa Wyrodek, Jan Manuel Rodriguez-Parkitna, Marian Kochman, Andrzej Ozyhar;
Temperature-sensitive ovarian carcinoma cell line (OvBH-1).
Jpn. J. Cancer Res. 93:976-985(2002)

PubMed=16364757; DOI=10.1016/j.cancergencyto.2005.04.011
Kamilla Schlade-Bartusiak, Maria Malgorzata Sasiadek, Julia Krystyna Bar, Steffi Urbschat, Nikolaus Blin, Mathias Montenarh, Antonina Urszula Harlozinska-Szmyrka;
Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).
Cancer Genet. Cytogenet. 164:10-15(2006)

PubMed=26925792; DOI=10.4149/315_150930N510
Jolanta Saczko, Justyna Pilat, Anna Choromanska, Nina Rembialkowska, Julia Krystyna Bar, Iwona Deszcz, Jerzy Zalewski, Julita Kulbacka;
The effectiveness of chemotherapy and electrochemotherapy on ovarian cell lines in vitro.
Neoplasma 63:450-455(2016)